Pulmonary Surface Liquid Homeostasis
Pulmonary Surface Liquid Homeostasis
批准号:
8658455
负责人:
Richard Charles Boucher
金额:
$211.05万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-05-15 至 2017-04-30
关键词:
AddressAdult Respiratory Distress SyndromeAlveolarBindingCell Culture TechniquesChronic Obstructive Airway DiseaseCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDiseaseDoctor of MedicineDoctor of PhilosophyEnvironmentFunctional disorderGoalsHealthHomeostasisHumanHuman bodyIon ChannelLengthLigandsLiquid substanceLungLung diseasesMaintenanceMolecularMolecular BiologyNucleotidesPathogenesisPhysiologicalPhysiologyPurinesPurinoceptorRegulationRelative (related person)RoleStressSurfaceSystems BiologyTemperatureairway epitheliumalveolar epitheliumbasedesignepithelial Na+ channelextracellularnovelnovel therapeuticspurinereceptor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The liquids that line the surface of the lung are critical for the maintenance of lung health. Focusing on CFTR, ENaC, and extracellular purines/purinoceptors, the PPG proposes to elucidate the molecular mechanisms that 1) regulate pulmonary surface liquid at local levels and 2) integrate airway and alveolar pulmonary surface liquid physiologies. To accomplish these goals, the PPG requires four Projects. Project I (Dynamics and Thermal Stability in CFTR Function and Dysfunction, J. R. Riordan, Ph.D., P.l.) proposes to study the mechanisms that confer temperature stability to wild-type CFTR, and, importantly, the temperature instability at physiologic temperatures of ?F508 CFTR. Project II (CFTR-ENaC Regulatory and Structural Interactions in Human Airway Epithelia, M.J. Stutts, Ph.D., P.l.) proposes to study the molecular basis for the regulatory relationship between CFTR and ENaC in airway epithelia at the structural, functional, and the regulatory levels. Project III (Purinergic Control of CFTR-ENaC Interactions in Alveolar Epithelia, R.C. Boucher, M.D., P.l.) proposes to study purinoceptor regulation of the CFTR-ENaC interrelationship on alveolar surfaces, focusing on the dominance of purinoceptor inhibition of ENaC in controlling the direction of alveolar liquid flow. Project IV (Mechanisms and Consequences of Nucleotide Release in the Lung, E. R. Lazarowski, Ph.D., P.l.) will investigate the mechanisms, regulation, and consequences of nucleotide release in airway epithelia, investigating the relative roles of vesicular vs. conductive release paths in health and their contribution to the pathogenesis of major airways diseases. The PPG Projects are supported by three Cores: an Administrative Core; a Cell Culture Core; and a Molecular Biology Core. By focusing on three major themes, i.e., CFTR, ENaC, and purinoceptor ligand-receptor interactions, from molecular to systems biology length scales, the PPG proposes to 1) generate a detailed molecular understanding of the regulation of Ion channel number/activity for local pulmonary surface liquid homeostasis and 2) integrate these activities over the entire surface of the lung to provide the framework for understanding normal physiology, disease pathogenesis, and design of novel therapies for major human lung diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UNC Research Training Program in Respiratory Diseases and Critical Care
-
批准号:10714527
-
项目类别:
-
资助金额:$52.69万
-
财政年份:2023
-
负责人:Richard Charles Boucher
-
依托单位:
The molecular and cellular mechanisms of the STAT3 mutation-mediated pulmonary disorder in Autosomal Dominant Hyper IgE Syndrome (AD-HIES)
-
批准号:10393987
-
项目类别:
-
资助金额:$74.85万
-
财政年份:2022
-
负责人:Richard Charles Boucher
-
依托单位:
Project 2: Why are mucins so gigantic and is it safe/effective to sever them therapeutically?
-
批准号:10684198
-
项目类别:
-
资助金额:$55.3万
-
财政年份:2022
-
负责人:Richard Charles Boucher
-
依托单位:
Core A: Administrative/Biostatistics Core
-
批准号:10684186
-
项目类别:
-
资助金额:$19.1万
-
财政年份:2022
-
负责人:Richard Charles Boucher
-
依托单位:
The molecular and cellular mechanisms of the STAT3 mutation-mediated pulmonary disorder in Autosomal Dominant Hyper IgE Syndrome (AD-HIES)
-
批准号:10584596
-
项目类别:
-
资助金额:$73.42万
-
财政年份:2022
-
负责人:Richard Charles Boucher
-
依托单位:
Diversity Supplement for PhD student Shamarie King under Multi-Scale Investigations of Respiratory Mucus/Mucin Structure and Function in Health and Disease
-
批准号:10852415
-
项目类别:
-
资助金额:$10.26万
-
财政年份:2022
-
负责人:Richard Charles Boucher
-
依托单位:
Multi-Scale Investigations of Respiratory Mucus/Mucin Structure and Function in Health and Disease
-
批准号:10684185
-
项目类别:
-
资助金额:$275.76万
-
财政年份:2022
-
负责人:Richard Charles Boucher
-
依托单位:
Mucin sialylation drives epithelial cell senescence and severe asthma
-
批准号:10206266
-
项目类别:
-
资助金额:$69.0万
-
财政年份:2020
-
负责人:Richard Charles Boucher
-
依托单位:
Mucin sialylation drives epithelial cell senescence and severe asthma
-
批准号:10664889
-
项目类别:
-
资助金额:$69.55万
-
财政年份:2020
-
负责人:Richard Charles Boucher
-
依托单位:
Mucin sialylation drives epithelial cell senescence and severe asthma
-
批准号:10026633
-
项目类别:
-
资助金额:$74.68万
-
财政年份:2020
-
负责人:Richard Charles Boucher
-
依托单位:
Mucin sialylation drives epithelial cell senescence and severe asthma
-
批准号:10434719
-
项目类别:
-
资助金额:$69.6万
-
财政年份:2020
-
负责人:Richard Charles Boucher
-
依托单位:
Development of Novel Mycolytic Therapies for Lung Disease
-
批准号:10001578
-
项目类别:
-
资助金额:$217.4万
-
财政年份:2017
-
负责人:Richard Charles Boucher
-
依托单位:
Project 2: PK/PD requirements for mucolytic therapeutic agents in vitro and in vivo
-
批准号:10001600
-
项目类别:
-
资助金额:$47.8万
-
财政年份:2017
-
负责人:Richard Charles Boucher
-
依托单位:
Core A: Program Management and Biostatistics Core
-
批准号:10001594
-
项目类别:
-
资助金额:$21.34万
-
财政年份:2017
-
负责人:Richard Charles Boucher
-
依托单位:
Core A: Program Management and Biostatistics Core
-
批准号:9356814
-
项目类别:
-
资助金额:$22.14万
-
财政年份:2017
-
负责人:Richard Charles Boucher
-
依托单位:
Synthesis of Effective and Safe Mucolytics for Pulmonary Disease
-
批准号:9144907
-
项目类别:
-
资助金额:$152.2万
-
财政年份:2014
-
负责人:Richard Charles Boucher
-
依托单位:
Synthesis of Effective and Safe Mucolytics for Pulmonary Disease
-
批准号:8754410
-
项目类别:
-
资助金额:$145.95万
-
财政年份:2014
-
负责人:Richard Charles Boucher
-
依托单位:
Pulmonary Surface Liquid Homeostasis
-
批准号:8467747
-
项目类别:
-
资助金额:$205.02万
-
财政年份:2012
-
负责人:Richard Charles Boucher
-
依托单位:
Novel Therapies for Muco-Obstructive Lung Diseases
-
批准号:8490422
-
项目类别:
-
资助金额:$242.37万
-
财政年份:2012
-
负责人:Richard Charles Boucher
-
依托单位:
Pulmonary Surface Liquid Homeostasis
-
批准号:8914311
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2012
-
负责人:Richard Charles Boucher
-
依托单位:
海外基金